p>세계의 셀프케어 의료기기 시장 규모는 2025년에 275억 달러로 평가되었습니다. 향후 IMARC Group은 2034년까지 450억 달러에 달하고, 2026년부터 2034년까지 CAGR 5.65%를 기록할 것으로 예측하고 있습니다. 북미가 현재 시장을 주도하고 있으며, 2025년에는 34.7% 이상의 점유율을 차지했습니다. 고령화 인구의 증가와 당뇨병, 고혈압 등 만성질환의 증가로 인해 셀프케어 의료기기에 대한 수요가 증가하고 있습니다. AI 기반 플랫폼, 웨어러블 기기, 비침습적 모니터링 기술 등의 기술 발전은 기기의 도입과 기능을 더욱 향상시키고 있습니다. 각 업체들은 경쟁력을 유지하기 위해 혁신적인 제품과 제휴를 통해 셀프케어 의료기기 시장의 성장을 확대하고 있습니다.
의료비 증가에 따라 셀프 케어 의료기기는 환자에게 비용 효율적인 솔루션을 제공합니다. 잦은 통원 및 입원의 필요성을 줄여 만성 및 급성 질환 관리에 있어 매력적인 선택이 되고 있습니다. 또한, 웨어러블 기술, 모바일 헬스 애플리케이션, 인공지능(AI) 기반 진단 도구의 지속적인 혁신은 다양한 셀프 케어 의료기기의 기능을 향상시키고 있습니다. 실시간 모니터링, 데이터 분석, 스마트폰과의 연동 등의 기능 강화로 인해 이러한 장비는 더욱 효율적이고 정확해져 기술에 정통한 사람들에게 매력적으로 다가갈 수 있게 되었습니다. 이와 더불어, 예방 의료 및 건강 상태의 자가 관리의 이점에 대한 사람들의 인식이 높아지면서 셀프 케어 의료기기의 보급을 촉진하고 있습니다. 개인이 스스로 건강관리를 하는 경향이 강해지면서 편리성, 정확성, 신뢰성을 겸비한 기기에 대한 수요가 증가하고 있습니다.
미국은 당뇨병, 고혈압, 호흡기질환 등 만성질환의 발병률이 증가함에 따라 미국 시장의 주요 지역입니다. 자가 관리 및 치료용 기기는 환자가 효과적으로 건강을 관리하고 의료 기관에 대한 의존도를 낮출 수 있도록 도와줍니다. 또한, 디지털 헬스 플랫폼의 보급이 확산되면서 예약, 약품 배송, 예방 의료 등의 서비스에 대한 원활한 접근을 제공함으로써 의료 관리를 혁신하고 있습니다. 이러한 플랫폼은 편의성을 높이고, 환자 참여를 촉진하며, 중요한 의료 자원에 대한 접근성을 확대할 수 있습니다. 예를 들어, 2024년 화이자는 미국에서 디지털 헬스 플랫폼 'PfizerForAll'을 도입했습니다. 이 플랫폼은 당일 예약 가능한 의료 서비스, 의약품 배송, 백신 예약, 화이자 의약품의 경제적 지원 등의 서비스를 제공하고 있습니다. 이 플랫폼은 미국 내 개인 의료 관리의 효율성과 서비스 접근성 향상을 목표로 하고 있습니다. 향후에는 더 많은 의료 수요에 대응하기 위한 확장이 계획되어 있습니다.
고령화 인구 증가
고령자 증가가 주요 촉진요인으로 작용하고 있습니다. 노인은 당뇨병, 고혈압, 심혈관질환, 관절염 등 만성질환에 걸릴 위험이 높기 때문입니다. 유엔(UN) 추산에 따르면, 65세 이상 인구는 2021년 7억 6,100만 명에서 2050년까지 16억 명으로 두 배 이상 증가할 것으로 예상됩니다. 80세 이상 인구는 더욱 빠른 속도로 증가하고 있습니다. 또한, 고령화는 수명 연장과 가족 규모 축소라는 인구학적 변화로 인해 젊은 층이 많은 국가에서도 되돌릴 수 없는 세계적인 현상입니다. 2021년에는 전 세계 인구 10명 중 1명이 65세 이상입니다. 이 연령층은 2050년까지 세계 인구 6명 중 1명을 차지할 것으로 추정됩니다. 따라서 고령화가 진행됨에 따라 혈당 측정기, 혈압계 등 이러한 상태를 관리하는 데 필수적인 셀프케어 의료기기의 판매도 증가하고 있습니다.
만성질환 증가 추세
당뇨병, 고혈압과 같은 만성질환의 전 세계 유병률은 상승 추세에 있습니다. 당뇨병은 개인, 가정, 그리고 국가적으로 심각한 문제로 대두되고 있습니다. 국제당뇨병연맹(IDF)의 당뇨병 아틀라스에 따르면, 전 세계 20-79세 성인 인구의 10.5%가 당뇨병을 앓고 있으며, 그 중 거의 절반이 당뇨병을 인지하지 못하고 있는 것으로 나타났습니다. IDF의 예측에 따르면, 2045년까지 약 7억 8,300만 명(8명 중 1명)의 성인이 당뇨병을 앓을 것으로 추정되며, 이는 현재보다 46% 증가한 수치입니다. 당뇨병 환자의 90% 이상을 차지하는 제2형 당뇨병은 사회경제적 요인, 인구통계학적 요인, 환경적 요인, 유전적 요인의 영향을 받습니다. 이에 따라 환자가 집에서 자가 관리 및 자가 모니터링을 할 수 있는 제품에 대한 수요가 증가하고 있습니다. 또한, 연속 혈당 모니터링 기기(CGM)와 혈압계는 이러한 상태 관리에 효과적이기 때문에 보급이 확대되고 있습니다. 예를 들어, CGM의 보급은 기술 발전과 가격 하락에 의해 뒷받침되고 있습니다.
기술적 진보
셀프케어 의료기기 시장의 성장은 인공지능(AI), 모바일 헬스 애플리케이션, 디지털 플랫폼의 급속한 통합에 의해 주도되고 있습니다. 이들은 기존의 임상 환경 밖에서 개인이 자신의 건강 상태를 모니터링하고 관리하는 방식을 변화시키고 있습니다. 웨어러블 기술, 비침습적 혈당 모니터링 등의 발전으로 셀프케어 의료기기의 새로운 혁신, 정확성, 기능성이 향상되고 있습니다. 예를 들어 2025년 서울대학교 공과대학 기계공학과 웨어러블소프트일렉트로닉스연구소 고승환 교수 연구팀이 반창고처럼 피부에 밀착되어 장시간 동안 혈압을 실시간으로 지속적으로 모니터링할 수 있는 웨어러블 전자장치를 개발했다고 발표하였습니다. 현재 주요 기업들은 이러한 요구에 부응하기 위해 첨단 제품 버전을 출시하고 있습니다. 예를 들어, 2024년 3월 18일, 존슨앤드존슨 메드텍은 엔비디아와 제휴하여 외과 수술의 AI 역량을 강화하기로 했습니다. 이번 협력은 엣지에서의 실시간 수술 데이터 분석을 가속화하여 수술의 효율성과 안전성을 높이는 것을 목표로 하고 있습니다. 존슨앤드존슨 메드텍은 또한 AI 모델의 개발 및 도입을 용이하게 하고, 자사의 디지털 수술 플랫폼에 확장 가능한 통합을 가능하게 할 계획입니다. 이러한 상황에서 각 업체들은 경쟁력을 유지하기 위해 끊임없이 신제품 등록을 신청하고 있으며, 이 또한 시장 성장을 촉진하는 요인으로 작용하고 있습니다.
The global self-care medical devices market size is anticipated to reach USD 27.5 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 45.0 Billion by 2034, exhibiting a CAGR of 5.65% from 2026-2034. North America currently dominates the market, holding a market share of over 34.7% in 2025. The growing geriatric population and rising chronic diseases like diabetes and hypertension are increasing demand for self-care medical devices. Technological advances, including AI-driven platforms, wearables, and non-invasive monitoring, further enhance device adoption and functionality. Companies are launching innovative products and partnerships to stay competitive, expanding the self-care medical devices market growth.
With healthcare expenses on the rise, self-care medical devices offer a cost-effective solution for patients. They reduce the need for frequent doctor visits and hospital stays, making them an attractive option for managing chronic and acute conditions. Moreover, continuous innovations in wearable technology, mobile health applications, and artificial intelligence (AI)-driven diagnostic tools are enhancing the functionality of various self-care medical devices. Enhanced features, such as real-time monitoring, data analysis, and integration with smartphones, are making these devices more efficient, accurate, and appealing to tech-savvy individuals. Apart from this, the growing awareness among people about the benefits of preventive healthcare and self-management of health conditions is driving the adoption of self-care medical devices. Individuals are more inclined to take control of their health, leading to higher demand for devices that offer convenience, accuracy, and reliability.
The United States is a key region in the market owing to the rising cases of chronic conditions such as diabetes, hypertension, and respiratory disorders among the masses, which self-monitoring and therapeutic devices. These devices empower patients to manage their health effectively and reduce dependence on healthcare facilities. Besides this, the growing adoption of digital health platforms is transforming healthcare management by offering seamless access to services, including appointments, medication delivery, and preventive care. These platforms increase convenience, boost patient involvement, and broaden access to vital healthcare resources. For instance, in 2024, Pfizer introduced PfizerForAll, a digital health platform in the US that provides services such as same-day healthcare appointments, medication delivery, vaccine reservations, and financial assistance for Pfizer medications. The platform seeks to streamline healthcare administration and enhance service accessibility for individuals in America. Future expansions are planned to include additional healthcare needs.
Rising Geriatric Population
The rise in the number of older individuals is acting as a major driver, as they have higher chances of acquiring long-term illnesses like diabetes, blood pressure, cardiovascular diseases, and arthritis. As per the United Nations (UN), the number of people 65 years and older will more than double, from 761 Million in 2021 to 1.6 Billion by the year 2050. The population 80 years and older is increasing at an even accelerated rate. In addition, aging population is an irreversible worldwide phenomenon fueled by the demographic transition of increased lifespans and reduced physical family size even among nations with young populations. In 2021, 1 out of 10 individuals globally was over the age of 65. The age group is estimated to account for 1 out of 6 individuals worldwide in 2050. Therefore, the increasing geriatric population is growing sales of self-care medical devices like blood glucose meters and blood pressure monitors that are vital in controlling these conditions.
Increasing Prevalence of Chronic Diseases
The global prevalence of chronic diseases like diabetes and hypertension is on the rise. Diabetes is a growing global challenge for people, households, and countries. 10.5% of the adult population aged 20-79 years worldwide has diabetes, and almost half of them are unaware of it, as per the International Diabetes Federation (IDF) Diabetes Atlas. IDF projections suggest that by 2045, there will be an estimated 783 Million adults, or 1 in 8, with diabetes, a 46% increase from today's number. Type 2 diabetes affects more than 90% of diabetes cases and is impacted by socio-economic, demographic, environmental, and genetic determinants. This generates demand for products that enable patients to self-monitor and control their condition in the home setting. In addition, continuous glucose monitors (CGMs) and blood pressure monitors are gaining traction because they are effective in controlling these conditions. For example, the penetration of CGMs has been supported by technology and growing affordability.
Technological Developments
The self-care medical devices market growth is being propelled by the rapid integration of artificial intelligence (AI), mobile health applications, and digital platforms that transform how individuals monitor and manage their health outside traditional clinical environments. The new innovations and precision and functionality of self-care medical devices are being enhanced by developments such as wearable technology and non-invasive glucose monitoring. For instance, in 2025, Seoul National University College of Engineering revealed that a research team headed by Professor Seung Hwan Ko from the Wearable Soft Electronics Lab in the Department of Mechanical Engineering has created a wearable electronic device that adheres to the skin like a bandage and allows for real-time, ongoing monitoring of blood pressure for prolonged durations. Currently, large companies are unveiling advanced product versions to meet these needs. For example, on 18 March 2024, Johnson & Johnson MedTech partnered with NVIDIA to boost AI abilities within surgical operations. This collaboration is also designed to speed up real-time surgical data analysis at the edge, making operations efficient and secure. Johnson & Johnson MedTech also intends to make it easier to develop and deploy AI models, enabling scalable integration in its digital surgery platform. As a result, firms are constantly applying for new product registrations to remain competitive, which is also driving market growth.
Self-monitoring of blood glucose (SMBG) stands as the largest component in 2025, holding 43.5% of the market share. Self-monitoring of blood glucose (SMBG) dominates the market, as it is crucial for diabetic patients to manage their blood sugar levels independently, driving significant demand globally. It typically includes glucose meters and continuous glucose monitoring systems (CGMs), offering convenience and real-time data for effective diabetes management. Additionally, the market for SMBG devices is characterized by ongoing technological advancements aimed at improving experience of the user, accuracy, and integration with digital health platforms. In February 2023, Afon Technology Ltd. announced on Twitter the introduction of a non-invasive blood glucose sensor, a wearable gadget launched in the beginning of 2024. It is entirely non-invasive and removes the necessity for needles or lancets, presenting a far more appealing choice for individuals managing diabetes. This segment is also fueled by the increasing prevalence of diabetes worldwide and the rising preference for home-based healthcare solutions, which is creating a positive self-care medical devices market outlook.
Geriatric accounts for the majority of the market share. Geriatric individuals aged 65 and above are driving the demand for self-care medical devices due to their increasing healthcare needs and desire for independent living. Moreover, the growing number of geriatric users often require devices for chronic disease management, mobility aids, and remote monitoring solutions to maintain health and quality of life. According to the World Health Organization (WHO) by 2030, one out of every six people worldwide will be 60 years of age or older. During this period, the population aged 60 years and above will rise from 1 Billion in 2020 to 1.4 Billion. By 2050, the global population of individuals aged 60 years and older is projected to double to 2.1 Billion. The number of people aged 80 years or older is expected to triple from 2020-2050, reaching 426 Million. Hence, manufacturers and healthcare providers are focusing on developing user-friendly, intuitive devices tailored to the needs and preferences of this demographic, thereby shaping the self-care medical devices market growth trajectory.
In 2025, pharmacies hold a notable market share of 42.5%. Pharmacies provide an easy way for consumers to obtain self-care tools like blood pressure monitors, glucose meters, and respiratory aids. Their existence in both urban and rural settings improves market reach, addressing various demographic requirements. Pharmacies gain from pharmacists' knowledge in suggesting appropriate devices, which enhances consumer trust and guarantees efficient self-care management, leading to an optimistic outlook for the self-care medical devices sector. According to the statistics from the Organization for Economic Cooperation and Development (OECD), between 2000 and 2019, the ratio of pharmacists to the population rose by almost 40% on average in OECD countries with accessible time series data, reaching 86 pharmacists for every 100,000 residents. Thus, this significance highlights pharmacies' vital function in delivering crucial medical equipment directly to individuals worldwide.
In 2025, North America accounted for the largest market share of 34.7%. North America primarily includes individual consumers seeking convenient healthcare options at home, driven by the aging population's desire for greater independence and control over their health. The market caters extensively to personal health monitoring devices, such as glucose monitors, blood pressure monitors, and wearable fitness trackers, which empower users to manage their health proactively and independently. According to an article published on 22 May 2024, researchers from the University of California San Diego have created a wearable ultrasound patch capable of continuously and non-invasively monitoring brain blood flow. This soft, flexible patch is worn on the temple, providing three-dimensional cerebral blood flow data, a pioneering achievement in wearable technology. The team, led by Professor Sheng Xu, disclosed their innovation in Nature. According to the self-care medical devices market forecast, the region is anticipated to experience significant growth in the coming years due to the increasing adoption of health-monitoring technologies and the rising demand for convenient at-home healthcare solutions.
United States Self-Care Medical Devices Market Analysis
The United States stands as one of the largest and most sophisticated market for self-care medical devices, characterized by exceptionally high healthcare expenditure exceeding three trillion dollars annually, advanced technological adoption across consumer segments, and increasingly comprehensive insurance coverage that now frequently reimburses remote patient monitoring solutions as cost-effective alternatives to traditional care delivery. The country faces a significant chronic disease burden, with conditions including diabetes, cardiovascular disease, chronic obstructive pulmonary disease, and sleep disorders affecting hundreds of millions of Americans and creating substantial ongoing demand for home monitoring equipment that enables condition management and complication prevention. The Centers for Medicare and Medicaid Services has strategically expanded reimbursement codes for remote patient monitoring services, creating financial incentives for both healthcare providers and patients to adopt self-care technologies as standard components of chronic disease management programs. Digital health platforms are proliferating rapidly, offering integrated services that combine device data collection with telehealth video consultations, electronic prescription management, medication adherence tracking, and personalized wellness coaching delivered through mobile applications. Regulatory support through Food and Drug Administration initiatives specifically focused on home-use devices and artificial intelligence-enabled diagnostics accelerates innovation cycles while maintaining rigorous safety standards through risk-based classification systems and post-market surveillance requirements. In December 2024, the Food and Drug Administration released final recommendations for streamlining the approval process for medical devices that use artificial intelligence, with the guidance recommending information to include in predetermined change control plans as part of marketing submissions for artificial intelligence-enabled medical devices, facilitating faster deployment of advanced self-care technologies while maintaining appropriate regulatory oversight and patient safety protections.
Europe Self-Care Medical Devices Market Analysis
Europe's self-care medical devices sector is distinguished by stringent regulatory standards that prioritize patient safety, strong governmental emphasis on health technology assessment, and accelerating adoption of digital health solutions supported by comprehensive national eHealth strategies. The European Union's Medical Device Regulation provides extensive oversight encompassing device lifecycle management, clinical evidence requirements, post-market surveillance obligations, and unique device identification, while simultaneously accommodating technological innovation through adaptive frameworks that recognize the dynamic nature of software-driven medical devices. The aging population across European nations, with many countries experiencing median ages above forty-five years, drives substantial demand for home-based monitoring solutions that enable independent living, reduce caregiver burden, and decrease healthcare system strain from chronic condition management. Countries are implementing ambitious national digital health strategies that integrate self-care devices into broader healthcare ecosystems with particular emphasis on interoperability standards ensuring device data flows seamlessly into electronic health records, and data protection compliance with the General Data Protection Regulation requirements for sensitive health information. The European Health Data Space initiative, agreed upon through landmark negotiations in March 2024, is revolutionizing healthcare delivery by granting individuals unprecedented access to their electronic health data while facilitating secure cross-border health data exchange, supporting the integration of self-care device data into comprehensive longitudinal health records that inform clinical decision-making. Throughout 2024 and into 2025, the European Commission has been actively updating medical device regulations, including the implementation of unique device identifier systems that enable device tracking throughout the supply chain, expert panel designations providing specialized scientific guidance, and enhanced guidance documents on software classification.
Asia Pacific Self-Care Medical Devices Market Analysis
The Asia Pacific region represents the fastest-growing geographic market for self-care medical devices globally, driven by enormous populations exceeding four billion people, rapidly rising disposable incomes particularly among expanding middle classes, increasing health awareness through public education campaigns, and substantial government initiatives to strengthen healthcare infrastructure and achieve universal health coverage goals. Countries including China, India, Japan, South Korea, and Southeast Asian nations are experiencing rapid adoption of digital health technologies and home-based medical devices as components of healthcare system modernization strategies. The region faces significant chronic disease burden with diabetes, cardiovascular disease, and respiratory conditions affecting hundreds of millions of individuals, combined with persistent healthcare access challenges particularly in rural and remote areas where clinical facilities remain limited, making self-care solutions particularly valuable for extending medical services to underserved populations and reducing geographic health disparities. Governments are implementing ambitious policies to encourage medical technology innovation through research funding, tax incentives, regulatory streamlining, and support for local manufacturing capabilities to reduce import dependence and create domestic medical device industries. Regional healthcare systems are increasingly incorporating remote monitoring platforms and telehealth consultation services, creating integrated digital ecosystems for self-care device deployment that connect patients, devices, and healthcare providers. In September 2024, Medtronic inaugurated Southeast Asia's first Robotics Experience Studio in Singapore, a state-of-the-art facility that focuses on skill-building in robotic-assisted procedures and artificial intelligence applications, supporting the region's rising demand for precision care and medical technology while strengthening the regional healthcare ecosystem by fostering collaboration between industry, academia, and healthcare providers, providing hands-on training for healthcare professionals, and facilitating access to cutting-edge technologies that improve patient outcomes across Southeast Asia.
Latin America Self-Care Medical Devices Market Analysis
Latin America is embracing self-care medical device technology with growing recognition of its potential to address persistent healthcare accessibility challenges and reduce strain on overburdened public health systems that struggle to meet population needs with limited budgets and resources. The region's healthcare infrastructure varies significantly between countries and within countries, with urban areas generally possessing better access to advanced medical technologies, specialist physicians, and diagnostic facilities compared to rural regions where basic healthcare services remain limited. Economic factors substantially influence adoption patterns, with price-sensitive markets driving particular demand for cost-effective self-monitoring solutions that provide value without premium pricing, while import tariffs and currency fluctuations affect device affordability and market dynamics. Governments are gradually implementing regulatory frameworks that balance essential safety requirements with pragmatic recognition of the need to improve healthcare access, with some countries establishing expedited approval pathways for devices already approved in reference markets.
Middle East and Africa Self-Care Medical Devices Market Analysis
The Middle East and Africa region is experiencing gradual but steady adoption of self-care medical devices, driven by ongoing healthcare infrastructure development, increasing chronic disease prevalence particularly in urban populations, and government initiatives to modernize health systems as components of broader economic development strategies. Gulf Cooperation Council countries including the United Arab Emirates, Saudi Arabia, and Qatar are investing heavily in healthcare technology as central elements of economic diversification strategies that reduce oil dependence and position these nations as regional healthcare hubs. African nations are exploring self-care solutions to extend medical services to remote populations with severely limited clinical access, recognizing that traditional healthcare delivery models cannot economically reach dispersed rural populations.
Major participants in the market are diligently concentrating on improving product innovation, broadening their digital health platforms, and reinforcing their distribution channels. They are putting resources into research and development to launch sophisticated, easy-to-use devices that offer enhanced accuracy and connectivity capabilities. Strategic alliances and collaborations are being emphasized to incorporate artificial intelligence and data analytics for customized healthcare solutions. Businesses are also broadening their market presence by focusing on emerging areas and modifying their products to cater to various consumer demands. Initiatives aimed at meeting regulatory standards and improving affordability are shaping their competitive approaches. In 2024, Oxymed introduced the SleepEasy Auto CPAP devices in India, which include advanced FlowSens algorithms, CSA detection, and adjustable therapy modes for improved sleep apnea treatment. These CE-certified products merge cost-effectiveness with global standards, highlighting Oxymed's growth in the respiratory care sector.